Albertson, Timothy E.
Hansen, Caitlin
Bihari, Smiti
Gayed, Juleen
Xu, Xia
Simón-Campos, J. Abraham
Dever, Michael E.
Cardona, Jose F.
Mitha, Essack
Baker, Jeffrey B.
Keep, Georgina
Oladipupo, Islamiat
Mensa, Federico J.
Feng, Ye
Ma, Hua
Koury, Kenneth
Mather, Susan
Ianos, Claudia Ana
Anderson, Annaliesa S.
Türeci, Özlem
Şahin, Uǧur
Gruber, William C.
Gurtman, Alejandra
Sabharwal, Charu
Kitchin, Nicholas
,
Funding for this research was provided by:
BioNTech
Pfizer
Article History
Received: 13 November 2023
Accepted: 19 January 2024
First Online: 15 March 2024
Declarations
:
: Timothy E. Albertson: None. J. Abraham Simón-Campos: AstraZeneca/Other-personal fees; Pfizer/Other-personal fees; Roche/Other-personal fees. Michael E. Dever: None. Jose F. Cardona: None. Essack Mitha: None. Jeffrey B. Baker: Pfizer/BioNTech/Other-received payment as a principal investigator for Study C4591007. Federico J. Mensa: BioNTech/Other-employee/Stock. Özlem Türeci: BioNTech/Board membership and board member/Advisor/Consultant/Honoraria/Intellectual property/Patents/Other-Cofounder and Chief Medical Officer/Stock. Uğur Şahin: BioNTech/Other-employee and board member/Stock. Caitlin Hansen, Smiti Bihari, Juleen Gayed, Xia Xu, Georgina Keep, Islamiat Oladipupo, Ye Feng, Hua Ma, Kenneth Koury, Susan Mather, Claudia Ana Ianos, Annaliesa S. Anderson, William C. Gruber, Charu Sabharwal, and Nicholas Kitchin are current or former employees of Pfizer and may hold stock or stock options.
: Both studies were conducted in accordance with the protocols and consensus ethical principles derived from international guidelines, including the Declaration of Helsinki and CIOMS International Ethical Guidelines, applicable ICH GCP Guidelines, and other applicable laws and regulations, including privacy laws. Participants or their legally authorized representatives provided informed consent, and participant assent if applicable, for enrollment in the studies.